Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-099644
Filing Date
2025-10-15
Accepted
2025-10-15 11:55:27
Documents
1
Period of Report
2025-10-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2528208-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2528208-1_4seq1.xml 4 3893
  Complete submission text file 0001104659-25-099644.txt   5386
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER British Columbia, Canada
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER British Columbia, Canada (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1226 CHARTER LANE AMBLER PA 19002
Business Address
Thorell Marella (Reporting) CIK: 0001826323 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 251394016